Literature DB >> 8153666

The chemotherapy of high-grade astrocytomas.

G J Lesser1, S Grossman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8153666

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  17 in total

1.  Novel drug delivery system using thermoreversible gelation polymer for malignant glioma.

Authors:  Takao Arai; Tatsuhiro Joki; Masaharu Akiyama; Miyuki Agawa; Yuichi Mori; Hiroshi Yoshioka; Toshiaki Abe
Journal:  J Neurooncol       Date:  2006-03       Impact factor: 4.130

2.  Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol).

Authors:  William J Bodell; Alexander P Bodell; Donald D Giannini
Journal:  Neuro Oncol       Date:  2006-10-03       Impact factor: 12.300

Review 3.  Polymeric drug delivery for the treatment of glioblastoma.

Authors:  Scott D Wait; Roshan S Prabhu; Stuart H Burri; Tyler G Atkins; Anthony L Asher
Journal:  Neuro Oncol       Date:  2015-03       Impact factor: 12.300

4.  Enhanced antitumor activity of sarCNU in comparison to BCNU in an extraneuronal monoamine transporter positive human glioma xenograft model.

Authors:  Z P Chen; G Wang; Q Huang; Z F Sun; L Y Zhou; A D Wang; L C Panasci
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

5.  Cisplatin but not BCNU inhibits urokinase-type plasminogen activator levels in human glioblastoma cell lines in vitro.

Authors:  Y Go; S K Chintala; A Rayford; E Gagercas; F Ali-Osman; B Venkaiah; R Sawaya; Z Gokaslan; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

Review 6.  Recognition and management of gliomas.

Authors:  S E Kaba; A P Kyritsis
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

Review 7.  The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation.

Authors:  D F Emerich; R L Dean; C Osborn; R T Bartus
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 8.  The expanding role of chemotherapy for pediatric supratentorial malignant gliomas.

Authors:  D C Lyden; W P Mason; J L Finlay
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

9.  Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newly diagnosed glioblastoma multiforme.

Authors:  In Sil Choi; Se Hoon Lee; Tae-You Kim; Jae Seug Bang; Sun Ha Paek; Suzy Kim; Il Han Kim; Dae Seog Heo; Yung-Jue Bang; Dong Gyu Kim; Hee-Won Jung; Noe Kyeong Kim
Journal:  J Neurooncol       Date:  2002-11       Impact factor: 4.130

10.  Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells.

Authors:  Hyangsoon Noh; Qingnan Zhao; Jun Yan; Ling-Yuan Kong; Konrad Gabrusiewicz; Sungguan Hong; Xueqing Xia; Amy B Heimberger; Shulin Li
Journal:  Cancer Lett       Date:  2018-07-06       Impact factor: 8.679
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.